Pricing Log in Create free account
Friday 6 November 2026 Export GEVO’s income statement to Excel — free account

Gevo, Inc.

GEVO Basic Materials Specialty Chemicals

Gevo, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $160.6 million, up 849.3% from fiscal 2024.

Revenue
+7.11%
EPS
−7,600.0%
Free cash flow
−167.5%
Total debt
+20.0%

Quarter to June 2026, against a year earlier

1.36 0.14 +11.48%
Market cap
$301.6M
P/E
0.0×
Fwd P/E
−2.3×
Dividend yield
—
F-score
4/9
Altman Z
−0.27
Beneish M
4.01
Dividend safety
0/100
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

Insider Decisions last twelve months

Bought, $m 0.10
Sold, $m 2.60
Trades a month
Jan 26 Apr 26 Jul 26 Oct 26
Buy — — — — — — — — 2 — — —
Sell 3 1 — 4 1 7 7 — 4 3 — —
Insider Ownership 0.77%

Capital & Financial Ratios $m

Size
Market Cap 301.63
Revenue ttm 177.51
Net income ttm (211.20)
Free cash flow ttm (56.65)
Net debt Q 109.71
Valuation
P/E 0.00
Forward P/E (2.33) (negative: loss-making)
Price / sales 1.63
Forward P/S Powerpack
Price / FCF 0.00
Price / book 1.06
Financial health
Current ratio Q 2.70 (at or above 1.5: strong)
Debt / equity Q 0.61
Interest coverage Q (30.49)
Growth
Revenue growth Q +7.11% (above 0%: growing)
Operating income growth Q −3,062.49% (below 0%: shrinking)
EPS, this year +72.34% (at or above 15%: strong)
EPS, next year A +94.58% (at or above 15%: strong)
Revenue, next year A +21.37% (at or above 10%: strong)
EPS, past 5 yrs —
EPS, next 5 yrs A +49.18% (at or above 15%: strong)

Green and red mark values outside typical ranges; (Q) is the latest quarter, (A) analysts’ estimates. How we judge →

Valuation vs history

EV/Sales, ten years
EV/Sales is 2.6×, against a ten-year median of 1.1×; over the ten years it ranged from −7.5× in 2023 to 1,082× in 2021.
P/S against its own 10 years 44.30%
10-year low 10-year high
P/B against its own 10 years 79.61%
10-year low 10-year high
EV/Sales against its own 10 years 45.86%
10-year low 10-year high

Dividends

Yield
—
Annual rate
—
Payout ratio
—

Assets vs Liabilities $m

2023 2024 2025 Q'26
Cash 376 191 110 58
Receivables 3 2 8 12
Inventory 4 5 19 19
Other — — — —
386 204 143 102
2023 2024 2025 Q'26
Payables 23 22 37 33
ST’ Debt 68 — — —
Other — — 41 3
91 24 79 38

Compound Annual Growth %

10y 5y 3y
Sales 18.21% 96.11% 415.09%
Cash Flow 0.00% 0.00% 0.00%
Earnings 0.00% 0.00% 0.00%
Book Value 25.44% 26.08% (8.34%)

Earnings Trends EPS, adjusted, against the consensus

Q2 FY26 Estimate −0.02 Actual −0.01

Earnings per share against the consensus, by quarter
Quarter Estimate Reported Result
Q3 FY25 −0.04 −0.03 Beat by 0.01
Q4 FY25 −0.03 −0.02 Beat by 0.01
Q1 FY26 −0.02 −0.05 Miss by 0.03
Q2 FY26 −0.02 −0.01 Beat by 0.01
Q3 FY26 0.04 — Reports 10 November 2026

EPS $

Mar Jun Sep Dec Year
’26 (0.09) (0.75) — — —
’25 (0.09) 0.01 (0.03) (0.02) (0.14)
’24 (0.08) (0.09) (0.09) (0.09) (0.34)
’23 (0.07) (0.06) (0.07) (0.08) (0.28)
’22 (0.08) (0.06) (0.19) (0.11) (0.44)
’21 (0.05) (0.09) (0.07) (0.08) (0.30)
’20 (0.64) (0.40) (0.09) (0.15) (0.71)
Fiscal quarters ending in the months shown.

Revenue $m

Mar Jun Sep Dec Year
’26 43 47 — — —
’25 29 43 43 45 161
’24 4 5 2 6 17
’23 4 4 5 4 17
’22 0 0 0 1 1
’21 0 0 0 0 1
’20 4 1 0 1 6
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 (21) (8) — — —
’25 (24) (3) (7) 20 (13)
’24 (16) (11) (11) (19) (57)
’23 (9) (9) (3) (33) (54)
’22 (12) (5) (16) (12) (44)
’21 (7) (12) (9) (20) (48)
’20 (7) (4) (4) (5) (19)
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 (30) (21) — — —
’25 (30) (8) (15) 9 (44)
’24 (34) (21) (21) (33) (108)
’23 (31) (28) (24) (26) (108)
’22 (44) (20) (46) (19) (128)
’21 (12) (22) (1) (80) (114)
’20 (8) (5) (4) (9) (25)
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

1.8
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to December

Ten-year view Analyst estimates Powerpack
Group Line 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 TTM Jun ’26 Trend 10 yrs 2026e 2027e 2028e Next 3/yr
Income, $m
Income, $m Revenue 27 28 33 24 6 1 1 17 17 161 178 +21.8% 195 206 211 +9.6%
Gross margin, % (36.03) (38.60) (26.49) (50.01) (171.01) (1,342.21) (640.26) 30.28 29.05 46.92 50.71 +83.0 pt
EBT (37) (25) (28) (29) (40) (59) (98) (66) (79) (33) (211) (1.5%)
EBT margin, % (136.80) (89.45) (85.13) (117.04) (725.90) (11,107.50) (8,341.02) (384.97) (464.91) (20.32) (118.98) +116.5 pt
Net income (37) (25) (28) (29) (40) (59) (98) (66) (79) (33) (211) (1.5%)
Per share, $
Per share, $ Revenue 141.73 33.79 6.74 2.01 0.10 0.00 0.01 0.07 0.07 0.69 0.75 (44.7%)
Earnings (193.60) (30.20) (5.74) (2.35) (0.71) (0.30) (0.44) (0.28) (0.34) (0.14) (0.89) (55.2%)
Cash flow (106.85) (25.31) (3.25) (1.71) (0.34) (0.25) (0.20) (0.23) (0.25) (0.06) (0.07) (56.7%)
Capex (30.93) (2.34) (0.46) (0.49) (0.10) (0.34) (0.38) (0.23) (0.22) (0.13) (0.17) (45.6%)
Free cash flow (137.78) (27.65) (3.71) (2.20) (0.44) (0.58) (0.58) (0.45) (0.47) (0.19) (0.24) (52.0%)
Book value 360.75 77.95 18.21 5.95 2.57 2.80 2.73 2.34 2.11 1.99 1.15 (43.9%)
Shares, m 0 1 5 12 57 196 222 239 232 234 235 +120.2%
Valuation, ×
Valuation, × P/E 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.0
P/S 0.48 0.36 0.29 1.15 43.67 1,572.24 343.15 16.24 28.63 2.91 1.63 200.9
P/B 0.19 0.15 0.11 0.39 1.65 1.53 0.67 0.50 0.99 1.00 1.06 0.7
EV/Sales (0.23) 0.46 (0.34) 1.10 29.81 1,066.02 56.06 (1.64) 25.34 3.68 2.63 118.0
EV/FCF 0.24 (0.56) 0.62 (1.00) (6.54) (5.41) (0.51) 0.26 (3.95) (13.58) (8.24) (3.0)
Cash, $m
Cash, $m Operating cash flow (21) (21) (16) (21) (19) (48) (44) (54) (57) (13) (16) (4.6%)
Capex (6) (2) (2) (6) (6) (66) (84) (54) (51) (30) (40) +19.8%
Free cash flow (26) (23) (18) (27) (25) (114) (128) (108) (108) (44) (57) +5.7%
Balance, $m
Balance, $m Working capital (1) 6 33 4 78 319 390 295 179 65 64 n/m
Net debt 6 8 (21) (1) (77) (273) (337) (307) (124) 55 110 +27.4%
Shareholders’ equity 69 64 89 73 146 547 605 557 489 466 273 +23.6%
Returns, %
Returns, % ROA (34.61) (24.49) (28.56) (28.60) (32.74) (14.85) (14.56) (9.80) (12.74) (5.19) (35.69) +29.4 pt
ROIC (19.85) (20.43) (20.41) (23.12) (24.19) (13.75) (23.93) (20.46) (15.51) (2.42) (29.79) +17.4 pt
ROE (63.32) (37.09) (36.73) (35.54) (36.72) (17.07) (17.00) (11.39) (15.02) (7.08) (56.98) +56.2 pt
People
People Employees 74 51 52 57 31 99 89 103 122 151 — +8.2%
Revenue/emp, $m 0.37 0.54 0.63 0.43 0.18 0.01 0.01 0.17 0.14 1.06 — +12.5%
Negative figures in brackets.
estimates

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Gevo, Inc. vs peers in Specialty Chemicals (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
ASPN Aspen Aerogels, Inc. $428.2M — (loss-making) — (loss-making) +16.66% (above 0%: growing) n/m −93.09% (below 0%: shrinking) 24.15% (8.36%) Compare
MNTK Montauk Renewables, Inc. $343.0M 38.8× 16.6× +19.71% (above 0%: growing) n/m +60.35% (above 0%: growing) 100.00% (0.14%) Compare
GEVO Gevo, Inc. $301.6M — (loss-making) — (loss-making) +7.11% (above 0%: growing) n/m −167.47% (below 0%: shrinking) 42.58% (369.25%)
ALTO Alto Ingredients, Inc. $284.7M 5.4× 9.7× +12.48% (above 0%: growing) n/m +1,443.92% (above 0%: growing) 6.77% 3.51% Compare
ASPI ASP Isotopes Inc. $263.7M — (loss-making) — (loss-making) +327.63% (above 0%: growing) n/m −182.92% (below 0%: shrinking) 28.89% (667.48%) Compare
FF FutureFuel Corp. $236.9M — (loss-making) — (loss-making) +120.69% (above 0%: growing) n/m +4,245.38% (above 0%: growing) 19.08% 14.29% Compare
OEC Orion S.A. $235.7M — (loss-making) — (loss-making) +4.86% (above 0%: growing) n/m +64.87% (above 0%: growing) 19.20% 4.82% Compare
CMT Core Molding Technologies Inc $186.3M 25.6× 44.8× +54.42% (above 0%: growing) −18.18% (below 0%: shrinking) −3,170.52% (below 0%: shrinking) 14.83% 1.76% Compare
HDSN Hudson Technologies, Inc. $172.1M — (loss-making) 33.2× −19.71% (below 0%: shrinking) −82.14% (below 0%: shrinking) +43.42% (above 0%: growing) 24.91% 5.47% Compare
Median of peers $250.3M 25.6× 24.9× +18.19% — +51.89% 21.68% 2.64%

All 61 Specialty Chemicals stocks →

Pay and ownership Proxy statement filed 9 April 2026

Chief executive’s pay

Year Total pay Actually paid $100 invested
2025 3.47m 3.02m 47.06
2024 3.10m 6.48m 49.18
2023 3.75m 1.54m 27.29
2022 3.46m (3.18m) 44.71
2021 11.02m 11.87m 100.71

Ownership

Directors and executive officers, together 7.09%
BlackRock, Inc. 6.59%
Total pay is as the Summary Compensation Table states it; actually paid revalues the year’s share awards at its end, as the SEC’s pay-versus-performance rule asks. $100 invested is what $100 in the company’s shares at the start of the earliest year shown was worth at each year’s end. Ownership is the proxy’s own table: the directors and officers as a group, and every holder of 5% or more. Read the proxy statement

Gevo, Inc. (GEVO) Latest News

29 Oct

Impact 3 · · GlobeNewswire

28 Oct

Impact 4 · · GlobeNewswire

27 Oct

Impact 4 · · Simply Wall St.

23 Oct

Impact 3 · · Zacks

22 Oct

Impact 4 · · GlobeNewswire

14 Oct

Impact 4 · · GlobeNewswire

13 Oct

Impact 3 · · StockStory

8 Oct

Impact 4 · · GlobeNewswire

1 Oct

Impact 4 · · GlobeNewswire

23 Sep

Impact 4 · · MarketBeat

16 Sep

Impact 4 ·

14 Sep

Impact 3 ·

26 Aug

Impact 3 ·

15 Aug

Impact 3 ·

13 Aug

Impact 4 · · The Motley Fool transcript

11 Aug

Impact 4 ·

6 Aug

Impact 4 · · MarketBeat transcript
Impact 4 ·
Impact 4 ·
Impact 4 ·

25 Jul

Impact 3 ·

16 Jul

Impact 3 ·

15 Jul

Impact 3 ·

23 Jun

Impact 4 · · GlobeNewswire

29 May

Impact 3 · · StockStory

18 May

Impact 3 · · StockStory

12 May

Impact 4 · · StockStory
Impact 3 · · Insider Monkey

11 May

Impact 3 · · Simply Wall St.

10 May

Impact 4 · · Insider Monkey
stockrow.com/GEVO · Data as of Jun 30, 2026 · For information only; not investment advice. · © 2026 stockrow.com